Intravitreal anti‐vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study.

Autor: Husum, Yngvil Solheim, Bråten, Ragnhild Haugli, Sæther, Erik Magnus, Moe, Morten Carstens, Kristiansen, Ivar Sønbø, Jørstad, Øystein Kalsnes

Publikováno v: Acta Ophthalmologica (1755375X); Aug2024, Vol. 102 Issue 5, p544-554, 11p

Switching to aflibercept versus continuing bevacizumab for treatment‐resistant neovascular age‐related macular degeneration: a one‐year comparative observational study.

Autor: Husum, Yngvil Solheim¹ (AUTHOR) YNGHUS@ous-hf.no, Moe, Morten Carstens^1,2 (AUTHOR) MORTMO@ous-hf.no, Bragadóttir, Ragnheiður^1,2 (AUTHOR) UXRADO@ous-hf.no, Jørstad, Øystein Kalsnes^1,2 (AUTHOR) OEYJOE@ous-hf.no

Publikováno v: Acta Ophthalmologica (1755375X). Dec2021, Vol. 99 Issue 8, pe1354-e1359. 6p.

Bilateral calcification of the optic nerve sheath: A diagnostic dilemma

Autor: Husum, Yngvil Solheim, Skogen, Karoline, Brandal, Petter, Rønning, Pål Andre, Wigers, Andreas Reidar, Evang, Johan Arild, Jørstad, Øystein Kalsnes

Publikováno v: In American Journal of Ophthalmology Case Reports June 2021 22

Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study.

Autor: Husum YS; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway ynghus@ous-hf.no., Moe MC; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; University of Oslo, Faculty of Medicine, Oslo, Norway., Fagerland MW; Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway., Eriksen EF; Pilestredet Park Specialist Centre, Oslo, Norway., Jørstad ØK; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; University of Oslo, Faculty of Medicine, Oslo, Norway.

Publikováno v: BMJ open ophthalmology [BMJ Open Ophthalmol] 2024 Dec 25; Vol. 9 (1). Date of Electronic Publication: 2024 Dec 25.